INSYS Therapeutics Reports First Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Insys Therapeutics (INSY) Plunges After Bankruptcy Warning
May 13, 2019 8:46 AM EDTInsys Therapeutics (NASDAQ: INSY) plunges 48% after warning it may have to seek bankruptcy protection.
Liquidity Update (highlights from StreetInsider)
As further discussed in our Form 10-Q for the period ended Mar. 31, 2019 (the Form 10-Q), while the company has no outstanding debt, available liquidity is limited to $87.6 million in cash and cash equivalents and investments as of Mar. 31, 2019, and the company expects to have continued negative cash flows from operating activities. The company has experienced recurring and increasing losses from operations over the previous 18 months due to significant declines in the TIRF... More



